LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 76.75 | 770.25 | 8918 | 11262 | 0.7918 | 0.8829 | MN20160304_L02 | K18 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 78.98 | 770.25 | 9999 | 11518 | 0.8681 | 0.9288 | MN20160304_L02 | I22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 78.98 | 770.25 | 9346 | 11518 | 0.8114 | 0.8957 | MN20160304_L02 | K18 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 81.20 | 770.25 | 10256 | 11766 | 0.8716 | 0.9314 | MN20160304_L02 | I22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 81.20 | 770.25 | 9716 | 11766 | 0.8257 | 0.9050 | MN20160304_L02 | K18 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 83.42 | 770.25 | 10575 | 12031 | 0.8789 | 0.9360 | MN20160304_L02 | I22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 83.42 | 770.25 | 10095 | 12031 | 0.8390 | 0.9134 | MN20160304_L02 | K18 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 85.64 | 770.25 | 10967 | 12287 | 0.8925 | 0.9439 | MN20160304_L02 | I22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 85.64 | 770.25 | 10522 | 12287 | 0.8563 | 0.9239 | MN20160304_L02 | K18 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 87.86 | 770.25 | 11319 | 12543 | 0.9024 | 0.9496 | MN20160304_L02 | I22 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.031667 | 87.86 | 770.25 | 10870 | 12543 | 0.8666 | 0.9301 | MN20160304_L02 | K18 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 3.21 | 770.25 | 1055 | 904 | 1.1662 | 2.8806 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 3.21 | 770.25 | 897 | 904 | 0.9916 | 0.9283 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 5.44 | 770.25 | 1084 | 1012 | 1.0704 | 1.3758 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 5.44 | 770.25 | 960 | 1012 | 0.9479 | 0.7466 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 7.66 | 770.25 | 1124 | 1090 | 1.0312 | 1.1265 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 7.66 | 770.25 | 1008 | 1090 | 0.9248 | 0.7109 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 10.06 | 770.25 | 1281 | 1218 | 1.0513 | 1.1570 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 10.06 | 770.25 | 1127 | 1218 | 0.9249 | 0.7775 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 12.28 | 770.25 | 1410 | 1358 | 1.0382 | 1.0938 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 12.28 | 770.25 | 1229 | 1358 | 0.9049 | 0.7701 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 14.50 | 770.25 | 1489 | 1497 | 0.9945 | 0.9885 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 14.50 | 770.25 | 1333 | 1497 | 0.8903 | 0.7718 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 16.73 | 770.25 | 1598 | 1664 | 0.9601 | 0.9280 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 16.73 | 770.25 | 1419 | 1664 | 0.8525 | 0.7326 | MN20160304_L02 | N06 |